221
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Lack of Motor Symptoms Progression in Parkinson's Disease Patients With Long-Term Bilateral Subthalamic Deep Brain Stimulation

, &
Pages 717-723 | Received 25 Feb 2010, Published online: 13 Oct 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Antonella Macerollo, Ludvic Zrinzo, Harith Akram, Thomas Foltynie & Patricia Limousin. (2020) Subthalamic nucleus deep brain stimulation for Parkinson’s disease: current trends and future directions. Expert Review of Medical Devices 17:10, pages 1063-1074.
Read now
Qifeng Sun, Dechun Zhao, Shanshan Cheng, Xiaorong Hou, Xing Zhao & Yin Tian. (2018) A feature extraction method for adaptive DBS using an improved EMD. International Journal of Neuroscience 128:10, pages 975-986.
Read now
Alberto J Espay, Alfonso Fasano & Francesca Morgante. (2012) The six gaps in the search of neuroprotection for Parkinson’s disease. Expert Review of Neurotherapeutics 12:2, pages 111-113.
Read now

Articles from other publishers (21)

Srestha Mazumder, Anita Y. Bahar, Claire E. Shepherd & Asheeta A. Prasad. (2022) Post-mortem brain histological examination in the substantia nigra and subthalamic nucleus in Parkinson’s disease following deep brain stimulation. Frontiers in Neuroscience 16.
Crossref
Maria Antonietta Volonté, Giacomo Clarizio, Sebastiano Galantucci, Pietro Giuseppe Scamarcia, Rosalinda Cardamone, Lina Raffaella Barzaghi, Monica Falautano, Pietro Mortini, Giancarlo Comi & Massimo Filippi. (2021) Long term follow-up in advanced Parkinson’s disease treated with DBS of the subthalamic nucleus. Journal of Neurology 268:8, pages 2821-2830.
Crossref
Alfonso Fasano & Marcelo Merello. (2020) Fading of Deep Brain Stimulation Efficacy Versus Disease Progression: Untangling a Gordian Knot. Movement Disorders Clinical Practice 7:7, pages 747-749.
Crossref
Jing Han Ng, Angela An Qi See, Zheyu Xu & Nicolas Kon Kam King. (2020) Longitudinal medication profile and cost savings in Parkinson’s disease patients after bilateral subthalamic nucleus deep brain stimulation. Journal of Neurology 267:8, pages 2443-2454.
Crossref
A.L. Sette, E. Seigneuret, F. Reymond, S. Chabardes, A. Castrioto, B. Boussat, E. Moro, P. François & V. Fraix. (2019) Battery longevity of neurostimulators in Parkinson disease: A historic cohort study. Brain Stimulation 12:4, pages 851-857.
Crossref
Anna Mallach, Maria Weinert, Joy Arthur, Djordje Gveric, Travis S. Tierney & Kambiz N. Alavian. (2019) Post mortem examination of Parkinson's disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus . The FASEB Journal 33:6, pages 6957-6961.
Crossref
Patricia Limousin & Tom Foltynie. (2019) Long-term outcomes of deep brain stimulation in Parkinson disease. Nature Reviews Neurology 15:4, pages 234-242.
Crossref
D. Luke Fischer & Caryl E. Sortwell. (2018) BDNF provides many routes toward STN DBS‐mediated disease modification. Movement Disorders 34:1, pages 22-34.
Crossref
Malco Rossi, Verónica Bruno, Julieta Arena, Ángel Cammarota & Marcelo Merello. (2018) Challenges in PD Patient Management After DBS: A Pragmatic Review. Movement Disorders Clinical Practice 5:3, pages 246-254.
Crossref
D. Luke Fischer, Fredric P. Manfredsson, Christopher J. Kemp, Allyson Cole-Strauss, Jack W. Lipton, Megan F. Duffy, Nicole K. Polinski, Kathy Steece-Collier, Timothy J. Collier, Sara E. Gombash, Daniel J. Buhlinger & Caryl E. Sortwell. (2017) Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein Overexpression. Scientific Reports 7:1.
Crossref
Napoleon Torres, Jenny Molet, Cecile Moro, John Mitrofanis & Alim Benabid. (2017) Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data. International Journal of Molecular Sciences 18:10, pages 2190.
Crossref
Y.-C. Chen, G.-Y. Zhu, L. Shi, A.-C. Yang, X. Wang, J.-G. Zhang, Y. Jiang & X. Zhang. (2017) Doesn't subthalamic nucleus deep brain stimulation have a neuroprotective effect in Parkinson's disease patients?. Acta Neurologica Scandinavica 135:4, pages 491-492.
Crossref
Gian D. Pal, Bichun Ouyang, Geidy Serrano, Holly A. Shill, Christopher Goetz, Glenn Stebbins, Leo Verhagen Metman, Erika Driver-Dunckley, Shyamal H. Mehta, John N. Caviness, Marwan N. Sabbagh, Charles H. Adler & Thomas G. Beach. (2017) Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation. Movement Disorders 32:2, pages 274-277.
Crossref
Christoph van Riesen, Georg Tsironis, Doreen Gruber, Fabian Klostermann, Patricia Krause, Gerd Helge Schneider & Andreas Kupsch. (2016) Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature. Journal of Neural Transmission 123:6, pages 621-630.
Crossref
Jihye Park, Chae-Seok Lim, Hyunhyo Seo, Chung-Ah Park, Min Zhuo, Bong-Kiun Kaang & Kyungmin Lee. (2015) Pain Perception in Acute Model Mice of Parkinson's Disease Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP). Molecular Pain 11, pages s12990-015-0026.
Crossref
Ilse S. Pienaar, Cecilia Heyne Lee, Joanna L. Elson, Louisa McGuinness, Stephen M. Gentleman, Raj N. Kalaria & David T. Dexter. (2015) Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease. Neurobiology of Disease 74, pages 392-405.
Crossref
Claire J. Williams & David T. Dexter. (2014) Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative disease. Journal of Neurochemistry 129:1, pages 4-20.
Crossref
David T. Dexter & Peter Jenner. (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radical Biology and Medicine 62, pages 132-144.
Crossref
David T. Dexter. 2013. Mechanisms and Metal Involvement in Neurodegenerative Diseases. Mechanisms and Metal Involvement in Neurodegenerative Diseases 58 79 .
Jill L. Ostrem, Nicholas B. Galifianakis, Leslie C. Markun, Jamie K. Grace, Alastair J. Martin, Philip A. Starr & Paul S. Larson. (2013) Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clinical Neurology and Neurosurgery 115:6, pages 708-712.
Crossref
Patrick Hickey & Mark Stacy. (2011) The surgical management of Parkinson’s disease. Neurodegenerative Disease Management 1:3, pages 203-215.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.